SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-079769
Filing Date
2024-03-28
Accepted
2024-03-28 08:22:54
Documents
17
Period of Report
2024-03-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d800096d8k.htm   iXBRL 8-K 37684
2 EX-4.1 d800096dex41.htm EX-4.1 93849
3 EX-4.2 d800096dex42.htm EX-4.2 96862
4 EX-10.1 d800096dex101.htm EX-10.1 177951
5 EX-99.1 d800096dex991.htm EX-99.1 7887
  Complete submission text file 0001193125-24-079769.txt   647202

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mtem-20240328.xsd EX-101.SCH 2878
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtem-20240328_lab.xml EX-101.LAB 17995
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtem-20240328_pre.xml EX-101.PRE 11280
21 EXTRACTED XBRL INSTANCE DOCUMENT d800096d8k_htm.xml XML 3674
Mailing Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729
Business Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729 512 896 1555
Molecular Templates, Inc. (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32979 | Film No.: 24793655
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)